Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT04479722

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04479722
Other papers using this trial's data
  • Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2026-07-06 DOI, PubMed 42405627, PMC13330120 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04479722. Randomized; no masking; primary purpose prevention. Start 2021-03-03 (actual); primary completion 2022-09-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
Acronym
SAFE-PROTECT
Condition
Stroke
Intervention (Device)
Left atrial appendage closure procedure
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04479722
Content hash
0f74c69ebb4f9ada718cd87ebaa77c84861feac416dfac80090512301ae6dc4c